203 related articles for article (PubMed ID: 35284810)
1. Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency.
Li CZ; Ogawa H; Ng SS; Chen X; Kishimoto E; Sakabe K; Fukami A; Hu YC; Mayhew CN; Hellmann J; Miethke A; Tasnova NL; Blackford SJI; Tang ZM; Syanda AM; Ma L; Xiao F; Sambrotta M; Tavabie O; Soares F; Baker O; Danovi D; Hayashi H; Thompson RJ; Rashid ST; Asai A
JHEP Rep; 2022 Apr; 4(4):100446. PubMed ID: 35284810
[TBL] [Abstract][Full Text] [Related]
2. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Xu J; Kausalya PJ; Van Hul N; Caldez MJ; Xu S; Ong AGM; Woo WL; Mohamed Ali S; Kaldis P; Hunziker W
Gastroenterology; 2021 May; 160(6):2103-2118. PubMed ID: 33465371
[TBL] [Abstract][Full Text] [Related]
3. Vps33b is crucial for structural and functional hepatocyte polarity.
Hanley J; Dhar DK; Mazzacuva F; Fiadeiro R; Burden JJ; Lyne AM; Smith H; Straatman-Iwanowska A; Banushi B; Virasami A; Mills K; Lemaigre FP; Knisely AS; Howe S; Sebire N; Waddington SN; Paulusma CC; Clayton P; Gissen P
J Hepatol; 2017 May; 66(5):1001-1011. PubMed ID: 28082148
[TBL] [Abstract][Full Text] [Related]
4. Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India.
Mehta S; Kumar K; Bhardwaj R; Malhotra S; Goyal N; Sibal A
J Clin Exp Hepatol; 2022; 12(2):454-460. PubMed ID: 35535061
[TBL] [Abstract][Full Text] [Related]
5. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
Overeem AW; Klappe K; Parisi S; Klöters-Planchy P; Mataković L; du Teil Espina M; Drouin CA; Weiss KH; van IJzendoorn SCD
J Hepatol; 2019 Aug; 71(2):344-356. PubMed ID: 30965071
[TBL] [Abstract][Full Text] [Related]
6. Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation.
Hayashi H; Osaka S; Sakabe K; Fukami A; Kishimoto E; Aihara E; Sabu Y; Mizutani A; Kusuhara H; Naritaka N; Zhang W; Huppert SS; Sakabe M; Nakamura T; Hu YC; Mayhew C; Setchell K; Takebe T; Asai A
Stem Cell Reports; 2021 Feb; 16(2):309-323. PubMed ID: 33450190
[TBL] [Abstract][Full Text] [Related]
7. Molecular overview of progressive familial intrahepatic cholestasis.
Amirneni S; Haep N; Gad MA; Soto-Gutierrez A; Squires JE; Florentino RM
World J Gastroenterol; 2020 Dec; 26(47):7470-7484. PubMed ID: 33384548
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.
Masahata K; Ueno T; Bessho K; Kodama T; Tsukada R; Saka R; Tazuke Y; Miyagawa S; Okuyama H
Surg Case Rep; 2022 Jan; 8(1):10. PubMed ID: 35024979
[TBL] [Abstract][Full Text] [Related]
9. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.
Ali I; Khalid S; Stieger B; Brouwer KLR
Mol Pharm; 2019 Mar; 16(3):1406-1411. PubMed ID: 30608704
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
[TBL] [Abstract][Full Text] [Related]
12. Newer variants of progressive familial intrahepatic cholestasis.
Vinayagamoorthy V; Srivastava A; Sarma MS
World J Hepatol; 2021 Dec; 13(12):2024-2038. PubMed ID: 35070006
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish abcb11b mutant reveals strategies to restore bile excretion impaired by bile salt export pump deficiency.
Ellis JL; Bove KE; Schuetz EG; Leino D; Valencia CA; Schuetz JD; Miethke A; Yin C
Hepatology; 2018 Apr; 67(4):1531-1545. PubMed ID: 29091294
[TBL] [Abstract][Full Text] [Related]
14. Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
Imagawa K; Takayama K; Isoyama S; Tanikawa K; Shinkai M; Harada K; Tachibana M; Sakurai F; Noguchi E; Hirata K; Kage M; Kawabata K; Sumazaki R; Mizuguchi H
Sci Rep; 2017 Feb; 7():41806. PubMed ID: 28150711
[TBL] [Abstract][Full Text] [Related]
15. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary transport.
Kullak-Ublick GA; Beuers U; Paumgartner G
J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
[TBL] [Abstract][Full Text] [Related]
17. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
Stieger B; Mahdi ZM
J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
[TBL] [Abstract][Full Text] [Related]
18. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
[TBL] [Abstract][Full Text] [Related]
19. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
Harris MJ; Kagawa T; Dawson PA; Arias IM
J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
[TBL] [Abstract][Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]